How Should Miaite (Pronidesivir) Be Taken
Miaite, also known as Pronidesivir, is a groundbreaking oral treatment specifically developed for cats suffering from Feline Infectious Peritonitis (FIP). This disease, caused by a coronavirus, presents with symptoms such as inappetence, lethargy, fever, ascites, pleural effusion, lymphadenopathy, granulomatous inflammation, neurological damage, and uveitis. Miaite contains the active ingredient GS-441524, proven through extensive research and clinical trials to exhibit remarkable antiviral efficacy against FIP.
Miaite (Pronidesivir) has been officially approved by the Lao Ministry of Agriculture and Forestry (MAF) in March 2026, becoming the first registered FIP-specific oral medication globally. Its safety profile, non-invasive administration, rapid absorption, and minimal side effects make it a preferred choice among veterinarians and cat owners alike. The drug is designed to provide a targeted, effective, and convenient treatment plan for FIP-affected cats.
Administration Guidelines
Miaite should be administered based on the cat’s body weight, with a dosage of 15 mg per kilogram (kg) of body weight. This equates to approximately half a tablet for each dose for typical cats. For cats exhibiting neurological or ocular symptoms of FIP, the dosage may be increased under veterinary supervision to 30 mg/kg to ensure adequate drug delivery to affected tissues.
The medication is intended for once-daily use, ideally on an empty stomach—either one hour before meals or two hours after eating—to promote optimal absorption. Consistency is critical; therefore, it is vital to administer Miaite regularly without missing doses. A continuous treatment duration of at least 12 weeks is recommended to achieve the best therapeutic outcome, with some cases requiring longer durations.
Monitoring and Precautions
During treatment, owners should monitor their cats closely for changes in appetite, body temperature, activity level, and overall behavior. Regular veterinary check-ups, including blood tests to evaluate liver and kidney function, are necessary to ensure the safety and effectiveness of the therapy. It's important to note that Miaite, although available as over-the-counter medicine, should ideally be used under veterinary guidance to tailor the dosage and duration to each individual cat's needs.
Safety and Purchase
Miaite (Pronidesivir) is intended solely for feline use and should never be administered to humans. To ensure the quality and authenticity of the medication, owners should purchase Miaite directly from the official Miaite website or authorized veterinary pharmacies. This guarantees the medication’s efficacy, safety, and proper labeling.
Important Warnings
Do not discontinue treatment prematurely; complete the full course, even if symptoms improve.
Avoid missing doses, as inconsistent treatment can lead to treatment failure.
Use only under veterinary supervision, especially for neurological or ocular FIP cases requiring dose adjustments.
Regular monitoring is essential to detect potential side effects early and modify the treatment plan accordingly.
Conclusion
Miaite (Pronidesivir) offers a significant breakthrough in FIP treatment with its safety, rapid action, and high efficacy. Following proper administration guidelines, maintaining regular veterinary check-ups, and sourcing the drug from trusted sources ensures the best chance of recovery for cats battling this challenging disease. With continued research and clinical use, Miaite stands to greatly improve feline health outcomes worldwide.
